Use of Codeine-Containing Analgesics in Children Under 12 Years of Age Subsequent to CYP2D6 Genetic Testing; Establishment of a Public Docket; Request for Comments

4 organizations filed 4 public comments on Use of Codeine-Containing Analgesics in Children Under 12 Years of Age Subsequent to CYP2D6 Genetic Testing; Establishment of a Public Docket; Request for Comments, at the Food and Drug Administration. The comment window closed 2160d ago.

Commenters (4)

• American Academy of Pediatrics (AAP)

  1 filing · confidence 97%
• Association for Molecular Pathologytrade assoc.

  1 filing · confidence 85%
• Society for Pediatric Anesthesiatrade assoc.

  1 filing · confidence 85%
• Society for Pediatric Pain Medicinetrade assoc.

  1 filing · confidence 85%